OKYO Pharma (OKYO) Amortization (2023 - 2025)

OKYO Pharma (OKYO) reported Amortization of $422281.0 for Q3 2025, down 77.04% year-over-year from $1.8 million in Q3 2024, and up 3921.72% quarter-over-quarter from $10500.0 in Q1 2025.

OKYO Pharma (OKYO) Amortization (2023 - 2025) Analysis & Trends

OKYO Pharma (OKYO) has 3 years of Amortization data on file, last reported at $422281.0 in Q3 2025.

  • Amortization for Q3 2025 came in at $422281.0, down 77.04% year-over-year; the trailing twelve-month figure through Sep 2025 was $422281.0 (down 77.04% YoY), and the FY2025 annual result was $242342.0, up 59.5% from the prior year.
  • Amortization improved to $422281.0 in Q3 2025 per OKYO's latest filing, from $10500.0 in the prior quarter.
  • Over five years, Amortization peaked at $1.8 million in Q3 2024 and troughed at $10500.0 in Q1 2025.
  • A 3-year average of $544797.2 and a median of $299766.0 in 2023 frame the typical range for Amortization.
  • The sharpest annual moves came in 2024 and 2025: Amortization surged 513.65% in 2024, then slumped 93.09% in 2025.
  • A 3-year view of Amortization shows it stood at $299766.0 in 2023, then surged by 513.65% to $1.8 million in 2024, then tumbled by 77.04% to $422281.0 in 2025.
  • Business Quant data shows OKYO's Amortization at $422281.0 in Q3 2025, $10500.0 in Q1 2025, and $1.8 million in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amort. (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -13.75 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -
9 Abivax 94.26 Bn 94.26 Bn - -
10 OKYO Pharma 244.98 Mn 240.76 Mn - 422,281.00

Historic Data

Download Data
DateValue
Sep 30, 2025 422,281.00
Sep 30, 2025 422,281.00
Mar 31, 2025 10,500.00
Mar 31, 2025 10,500.00
Sep 30, 2024 1.84 Mn
Sep 30, 2024 1.84 Mn
Mar 31, 2024 151,938.00
Mar 31, 2024 151,938.00
Sep 30, 2023 299,766.00
Sep 30, 2023 299,766.00